Pinnacle Gription Tf
Payments companies reported to CMS as associated with Pinnacle Gription Tf. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pinnacle Gription Tf, per program year, as reported to CMS.
Who makes it
- Depuy Synthes Products, INC. $5.7M associated with Pinnacle Gription Tf (2023-2025)
- Medical Device Business Services, INC. $366K associated with Pinnacle Gription Tf (2023-2025)
- Depuy Synthes Sales INC. $6,935 associated with Pinnacle Gription Tf (2023-2025)
- Ethicon US, LLC $3,750 associated with Pinnacle Gription Tf (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pinnacle Gription Tf
These are the largest totals companies reported as associated with Pinnacle Gription Tf. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Trousdale | Rochester, MN | Orthopaedic Surgery | $5,243,928.44 |
| Kirk Kindsfater | Fort Collins, CO | Adult Reconstructive Orthopaedic Surgery | $354,415.90 |
| Robert Jones | Ozark, MO | Orthopaedic Surgery | $117,621.76 |
| Anay Patel | Houston, TX | Adult Reconstructive Orthopaedic Surgery | $106,715.26 |
| James Germano | Rockville Centre, NY | Orthopaedic Surgery | $92,458.92 |
| Jonathon Spanyer | Cincinnati, OH | Orthopaedic Surgery | $44,568.23 |
| Michael Gardner | Stanford, CA | Orthopaedic Trauma | $28,820.86 |
| Jon Minter | Alpharetta, GA | Orthopaedic Surgery | $19,615.62 |
| Joel Politi | Gahanna, OH | Orthopaedic Surgery | $19,558.88 |
| Patrick Strotman | Elmhurst, IL | Orthopaedic Surgery | $105.54 |
Prescribed Pinnacle Gription Tf?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.